Burning Rock Biotech Earning Date (BNR)

USA |NASDAQ |USD

BNR Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
May 23, 2022 Mar 2022 $-0.29 $-2.40 $-0.26
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
May 23, 2022 Mar 2022 $20.57M - $106.62M

Burning Rock Biotech's next earnings date is Monday, May 23, 2022 for the fiscal quarter ending Mar 2022.

BNR Earnings Date & History Chart

BNR Earnings & Revenue Forecast

BNR Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $-1.01 $-1.15 $-0.86

BNR Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 2 $-0.75 $-0.75 $-3.05

BNR Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $107.42M $91.96M $121.02M

BNR Earnings Date & Revenue History

BNR Earnings History

|
Show More
Show More

BNR Revenue History

|
Show More
Show More

Burning Rock Biotech Next Earnings Date & Report

BNR Next Earnings Date & Report Preview: Mar 2022 (FQ)

BNR's next earnings date is Monday, May 23, 2022 for the fiscal quarter ending Mar 31, 2022.

According to analysts, the average EPS estimation for Burning Rock Biotech's next quarterly earnings is $-0.29, with a low EPS estimation of $-0.29, and a high estimation of $-0.29.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 1 downward. The EPS 1 month trend is $-0.27, the last 2 month trend is $-0.27, and the 3 month trend is $-1.50.

Based on analysts, the average revenue estimation is $20.57M, with a low revenue estimation of $20.57M, and a high estimation of $20.57M.

Burning Rock Biotech Previous Earnings Dates & Reports

BNR Previous Earnings Date & Report Recap: Dec 2021 (FQ)

Burning Rock Biotech's previous earnings date was Mar 21, 2022 for its fiscal quarter ended Dec 31, 2021.

BNR's earnings per share (EPS) was $-2.40, missing the consensus analysts forecast of $-1.69 by -42.01%.

The EPS was lower than the previous fiscal quarter (Sep 2021) by 835.67%, and lower than the same period a year before (Dec 2020) by 932.26%.

Free cash flow for the quarter was $-112.35M , compared to $-133.39M last quarter and $-170.20M a year before.

BNR ended the quarter with $86.69M in total debt, a decrease of -14.21% compared to the previous quarter, and an increase of 84.90% compared to the same quarter a year before.

BNR Previous Earnings Date & Report Recap: Dec 2021 (FY)

Burning Rock Biotech's previous annual earnings date was Mar 21, 2022 for its fiscal year ended Dec 31, 2021.

BNR's earnings per share (EPS) was $-3.22, missing the consensus analysts forecast of $-1.10 by 192.48% , and lower than the previous year's EPS (Dec 2020) by 299.91%.

Revenues were $507.86M, better than the forecast of $77.80M by 552.78%, and up by 18.13% from previous year's revenue.

The company reported a net income of $-796.70M.

Burning Rock Biotech reported a free cash flow of $-477.89M for its fiscal year, compared to $-153.08M a year ago.

The company ended the fiscal year with $86.69M in total debt, an increase of 84.90% compared to the previous year.